Literature DB >> 33563149

Administration of antioxidants in the infertile male: When may it have a detrimental effect?

Fotios Dimitriadis1, Evangelos N Symeonidis1, Panagiota Tsounapi2, Aris Kaltsas3, Georgios Hatzichristodoulou4, Ioannis Sokolakis4, Athanasios Zachariou3, Atsushi Takenaka2, Nikolaos Sofikitis3.   

Abstract

BACKGROUND &
OBJECTIVE: Significant advances in the field of male infertility have been witnessed during the last years. Given the well-known detrimental effects of reactive oxygen species (ROS), the administration of antioxidants has emerged as a promising solution for oxidative stress (OS)-induced male infertility. Nevertheless, this perception seems largely oversimplified, and the existing literature fails to recognize a notable superiority of the excessive use of these widely available nutritional compounds. Taking into consideration that several trials have shed light on the so-called "antioxidant paradox" phenomenon, we recognize that over-the-counter consumption of such supplements might be harmful.
METHOD: The relevant studies indexed in PubMed, Google Scholar and Scopus databases, published until September 2019 were identified and reported.
CONCLUSION: In this setting, we acknowledge that there is an eminent need for more elaborate studies in the future which will efficiently elucidate the risks and benefits of antioxidants on semen parameters and their impact on fertility potential. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  antioxidant paradox; antioxidants; male infertility; oxidative stress.; reactive oxygen species; reductive stress

Year:  2021        PMID: 33563149     DOI: 10.2174/1381612827666210204160248

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  1 in total

1.  Successful microsurgical vasoepididymostomy for a case of cryptozoospermia.

Authors:  Ru-Hui Tian; Yu-Hua Huang; Hui-Xing Chen; Peng Li; Er-Lei Zhi; Chen-Cheng Yao; Chao Yang; Zheng Li
Journal:  Asian J Androl       Date:  2022 Jul-Aug       Impact factor: 3.054

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.